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1. Introduction
Gastrointestinal symptoms are frequently encountered in women diagnosed with endome‐
triosis. Women with endometriosis appear to complain more commonly of gastrointestinal
symptoms such as gastro-oesophageal reflux and dyspepsia. The psychological profile of
patients with endometriosis may promote these symptoms. As a reaction to high levels of
perceived stress, neuroendocrine-immune imbalance has been demonstrated in women
diagnosed with endometriosis. Pharmacological agents used to treat psychological dysfunc‐
tion, and symptoms of endometriosis such as dysmenorrhoea, may lead to undesirable
gastrointestinal symptoms.
Through neuroendocrine and immunological intermediaries, the gastrointestinal system may
also interact with the physiology of the female genital system. These variables have directed
some workers to suggest an interrelationship between both systems including the occurrence
of pathology. Gastrointestinal symptoms may act as a guide to dietary modification which
may result in improvement in the symptomatology of endometriosis.
2. Epidemiology of gastrointestinal symptoms and endometriosis
It is becoming apparent that although anatomically separate, gastrointestinal symptoms do
overlap with pelvic endometriosis. Endometriosis is the occurrence of endometrial tissue
outside the uterus. Endometriotic deposits are mainly found on the ovaries, utero-sacral
ligaments and pelvic peritoneum. Endometriosis affects one fourth of young women under
the age of 30 years with an overall incidence of 7% to 10 % of women. Subfertility has been
noted in 20-50% of women found to have endometriosis while more than 80% of women
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complaining of chronic pelvic pain have been diagnosed as having this condition. Conversely
endometriosis has been diagnosed in 20-50% of women who were completely asymptomatic,
unaware that they had this pelvic pathology [1].
Gastrointestinal symptoms appear more prevalent in women diagnosed with pelvic endome‐
triosis [2,3,]. Specific signs and symptoms result in frequent medical consultation are associ‐
ated with presence of endometriosis [4]. The anatomical separation between the
gastrointestinal tract and the female genital tract may prima facie, appear disparate without
any anatomical or physiological association. In a study by Muscat Baron et al [5,6] however,
gastrointestinal symptoms such as heartburn and dyspepsia were significantly more com‐
monly found in women with endometriosis as compared to a control group. This was a
prospective trial involving 57 menstrual women who had undergone laparoscopic examina‐
tion of the pelvis for a diverse number of abdominal and gynaecological symptoms. The
women recruited to the study were asked a comprehensive questionnaire which included
information on gastrointestinal symptoms, gynaecological symptoms, dietary intolerance and
general symptoms. During laparoscopy 23 women were diagnosed as having pelvic endome‐
triosis while in the other thirty-four this diagnosis was excluded. Upper gastrointestinal
symptoms such as heartburn and dyspepsia were found more commonly in the endometriosis
group reaching statistical significance (p <0.001). These results posed the enquiry as to why
two apparently anatomically distant systems, that is the gastrointestinal tract and the female
reproductive system, should influence each other [5,6].
Women diagnosed with endometriosis have been shown to have concomitant irritable bowel
syndrome symptoms. Ballard et al have shown that women with pelvic endometriosis were
also diagnosed with irritable bowel syndrome (OR 1.6 [95% CI: 1.3-1.8]) [4]. Lower gastro-
intestinal symptoms in the form of diarrhoea and loose stools have been found more commonly
found in women diagnosed with endometriosis. As opposed to the upper gastro-intestinal
tract, both the small and to a greater extent the large bowel is in close proximity with the female
genital tract. Both systems (intestinal and reproductive) throughout their physiological
functioning are likely to influence each other [5,6].
It must be kept in mind that gastrointestinal symptoms commonly occur in the general
population. Although estimates vary according to the diagnostic criteria used, 10–40% of the
adult population experience heartburn and dyspepsia in Western countries. Gastro-oesopha‐
geal reflux disease increases with age, rising sharply beyond the fourth decade. More than half
of the patients effected are aged between 45 and 64[7].
Dyspepsia also affects between 20% and 40% of the Western populations. A quarter of all cases
of dyspepsia are though to be related to gastric and duodenal ulcers [8]. Several studies from
the 1940’s to the 1980's reported that population prevalence of 18%[9], 26%[10] and 31% [11]
of people referred with dyspepsia were found to have peptic ulcers. Recently this percentage
has fallen to around 10–15%[7]. Although mortality in people with gastrointestinal disorders
is not raised compared with the general population, these disorders have a significant impact
on quality of life. It has been shown that 75% of people with heartburn and dyspepsia suffered
persistent symptoms and impaired quality of life over periods of 10 years or more; 30–50%
never returned to work and were unable to carry out household tasks [12].
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3. Pathogenesis of endometriosis and gastrointestinal symptoms
The enigmatic pathogenesis of endometriosis has led to the formulation of several hypotheses,
but none have been proven conclusively. The elusiveness of its pathology has directed some
workers to search beyond the female genital tract and concentrate their efforts at the gastro‐
intestinal system, the small and large bowel being in close anatomical proximity to the female
genital tract (Figure 1.)[5,6,13]. The overlap of symptoms between both the gastrointestinal
pathology and endometriosis influences clinical practice and in several women leads to
delayed or misdiagnosis (Figure 1.).



















Figure 1. Following retrograde menstrual flow through the Fallopian tubes, endrometriotic deposits colonize adja‐
cent peritoneal structures. The peritoneal structures involved include ovaries, utero-sacral ligaments and adjacent
bowel especially the rectosigmoid colon. Following endometriotic deposition adhesion formation results. This may
lead to a retroverted uterus due to endometriosis-included adhesions between rectosigmoid colon and posterior as‐
pect of uterus, with obliteration of the Pouch of Douglas.
Physiological studies indicate that gastric emptying does not appear to be affected by the
menstrual cycle. Abdominal symptoms related to the upper gastrointestinal tract appear more
commonly during the follicular phase. During the follicular phase the transit time in the small
bowel is longer. The normal menstrual cycle has no effect on gastric motility suggesting that
gastric emptying does not change significantly between the follicular and luteal phases [14].
Almost 50% of women with irritable bowel syndrome report a perimenstrual increase in
symptoms [15].
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4. Psychological background to the co-existence of endometriosis and
gastrointestinal symptoms
Emotional and mood disorders in women have been significantly detected in women suffering
from endometriosis. These disorders were found more commonly in women with endome‐
triosis (11/23 p < 0.03), admitting regular administration of anxiolytic and/or anti depressant
therapy for symptoms related to significant anxiety or depression [5].
In a prospective study by [16], out of 104 women diagnosed with pelvic endometriosis 87.5%
of women complained of anxiety. This anxiety state was mild in 24% and severe in 63.5% of
the subjects studied. Correlations between pain intensity and anxiety symptoms, were also
obtained using the State-Trait Anxiety Inventory (STAI) (state, P=0.009; trait, P=0.048) and the
Hamilton Rating Scale for Anxiety (HAMA) (P=0.0001). Moreover anxiolytic treatment with
benzodiazepines such as clonazepam has been used in women with endometriosis. A number
of these subjects also required prolonged treatment with serotonin selective serotonin re-
uptake inhibitors (SSRI’s) [16].
Depression has also been noted to be prevalent in women with pelvic endometriosis, a high
proportion of which require anti-depressant therapy. Depressive symptoms were observed in
86.5% of patients with pelvic endometriosis (mild in 22.1%, moderate in 31.7%, and severe in
32.7%) [16]. In a similar percentage (86%) of women, depression was detected in the women
with endometriosis complaining of chronic pelvic pain [17]. Work inhibition, dissatisfaction,
and sadness, were observed at a significantly higher rates in the group with abdominal pain
[17]
The above mentioned psychological profile of these women may have been moulded from a
very young age. The cyclical experience of the symptoms of severe dysmenorrhoea and
menstrual disorders from puberty, may have conditioned these women to acquire certain
personality traits as a reaction to the cyclical physical and subsequent psychological suffering
they sustained [16]. Lower quality of life indices correlated with high pain scores. Lower
quality of life status in psychological and environmental perspectives resulted in an inverse
relationship between pain scores and the psychological dimension of quality of life (r = -0.310,
P =.02)[18].
Mood disorders in adult women with endometriosis are associated with co-morbidities such
as pain syndromes including irritable bowel syndrome, vulvodynia, fibromyalgia and asthma
have been noted with in adult women with endometriosis. These co-morbidities appear to
have their conception early in reproductive life in adolescents and young women. A study by
Smorgick et al (2013) reviewing 138 adolescents/young women (younger than 24 years)
demonstrated a prevalence of comorbid pain syndromes 56% women, mood conditions in 66
(48%) women, and asthma in 31 (26%) women [19].
Exacerbations of gastrointestinal motility disorders such as gastro-oesophageal reflux and
irritable bowel syndrome are associated with the emergence of psychosocial stressors. Naliboff
et al [20] assessed 60 subjects with current heartburn symptoms and correlated for the
occurrence of stressful life events retrospectively over the preceding 6 months and prospec‐
Dyspepsia - Advances in Understanding and Management172
tively for 4 months. The occurrence of a severe, sustained life stress during the previous 6
months significantly predicted increased heartburn symptoms during the following 4 months.
Anxiety showed the strongest correlation to impaired quality of life and depression to
heartburn medication use. Similar to other chronic conditions such as irritable bowel syn‐
drome, heartburn severity appears to be most responsive to major life events. Both heartburn
and irritable bowel syndrome may be related to gastrointestinal motility disorders[20]. In the
upper gastrointestinal tract oesophageal acid exposure due to inhibition of gastric emptying
of acid may lead to heartburn. Alternatively motility disorders affecting the lower intestinal
tract lead to irritable bowel syndrome.
On further investigation of gynaecological complaints, once the diagnosis of endometriosis is
established, the phobia of infertility may set in, further compounding the psychological profile.
If infertility does occur in these women, then depressive symptoms are more likely to appear.
Self-reported depression was more common in subfertile women (n = 1,031), with endome‐
triosis (O.R. 5.43, C.I. 4.01-7.36) compared with fertile women (n = 4,905) [21].
5. Neuro-endocrine imbalance in association with Gastrointestinal
symptoms and Endometriosis
The majority of women suffering from endometriosis are well versed in their condition. With
easy access to medical literature, besides subfertility, the risk of inflammatory bowel disease
and ovarian cancer has now become universally known to most women suffering from
endometriosis [21]. All these factors exacerbate the tenuous emotional status of these women
(Figure 2.)
In response to high levels of perceived stress, neuroendocrine-immune imbalance has been
alluded to as a reaction to the symptoms of endometriosis. Serum prolactin levels were
significantly higher in infertile women with stage III-IV endometriosis (28.9 +/- 2.1 ng/mL) than
in healthy controls (13.2 +/- 2.1 ng/mL)[22]. Elevated serum cortisol levels were noted in
infertile women with stage III-IV endometriosis (20.1 +/- 1.3 ng/mL) compared to controls (10.5
+/- 1.4 ng/mL) [22]. Perception of stress has been noted to trigger or intensify the incidence or
exacerbation of diseases such as inflammatory bowel disease, immunological cutaneous
conditions, or pregnancy complications such as spontaneous miscarriage and pre-eclampsia.
The effect on the immunity of the intestinal mucosa by stress has been implicated as a potential
mechanism leading to irritable bowel syndrome. This is thought to be mediated through
altered function of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous
system. Both of these systems can modulate mucosal immune function. A study by Chang et
al indicated that basal adrenocorticotropin hormone levels were significantly blunted (P <
0.05), while basal and stimulated plasma cortisol levels were higher in patients with irritable
bowel syndrome. Patients with irritable bowel syndrome presenting with diarrhoea had
significantly decreased mRNA expression of mucosal cytokines [interleukin (IL)-2, IL-6] in the
sigmoid colon versus controls (P < 0.05) [24].
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The association between psychological status and the gastrointestinal tract is well established.
Dr William Beaumont in 1833 demonstrated the influence of psychological stress on gastric
mucosal changes. Acclaimed as the Father of Gastric Physiology, Dr Beaumont carried out
observations and experiments on an individual known as Alexis St Martin. St Martin had
sustained a gastric fistula followed gunshot wound to the stomach, exposing a sliver of gastric
mucosa. Beaumont observed that the exposed gastric mucosa instantly reddened when St
Martin was angered, connecting the neuroendocrine-emotional status with gastric physiology
[25].
Heartburn and dyspepsia are acknowledged symptoms related with psychological and mood
disorders. Gastro-oesophageal reflux disease can be anatomically traced back to dysfunction
of the gastro-oesophageal junction, however psychological factors can play an important role
in the exacerbation of heart-burn. Well defined personality factors modulate the effect of stress
on the gastro-oesophageal junction, just as they can influence the perception and assessment
of symptoms. Gastric and small intestinal motor disorders and stomach acid hypersecretion,
interact with psychological and neurohormonal resulting in the pathogenesis of dyspepsia.
Greater proximal extension of acid during reflux episodes has been demonstrated in patients
with proven gastro-oesophageal reflux disease. These patients describe a shorter history of
symptom onset and worse anxiety scores. Endoscopic investigation depict findings compatible
with gastritis [26].
Altered secretion of gastric acid in the stomach has been linked with a vast array of modulators
supporting the neuro-endocrinological connection. Central neurotransmitters and/or neuro‐
modulators may excite or inhibit gastric acid secretion. Excitatory neuro-endocrine modulators
such as gamma-aminobutyric acid (GABA), acetylcholine, thyrotropin releasing hormone,
Increased Prolactin and 
Cortisol secretion











Figure 2. The secretion of central neurotransmitters and hormones such as cortisol and prolactin increase the secre‐
tion of gastric acid. This compounded by dietary indiscretion and injudicious ingestion of nonsteroidal inflammatory
agents increase risk for gastric mucosal ulceration.
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oxytocin have been cited. On the contrary, noradrenaline, adenosine, bombesin, calcitonin-
gene related peptide, corticotropin releasing factor, beta-endorphin, neurotensin, neuropep‐
tide Y, insulin-like growth factor II and prostaglandins have been shown to inhibit gastric acid
secretion.
Several of these neuro-endocrine mediators have also been noted in endometriosis. Deep
infiltrating endometriosis is associated with severe and frequent chronic pelvic pain. In these
cases significantly more nerve fibres are detected histologically, than in superficial peritoneal
endometriotic lesions. Deep infiltrating endometriotic lesions were shown to be innervated
abundantly by sensory nerve fibres utilizing acetylcholine and norepinephrine as neurotrans‐
mitters [27]. Women with endometriosis have been noted to have lower levels of progesterone
in serum in the follicular phase and progesterone levels were inversely correlated to pain
scores. Progesterone receptor positive peritoneal lymphocytes of CD56(+) and CD8(+) type
were increasing found in advanced endometriosis. Cytokine secretion by peritoneal cells, was
higher in cells derived from endometriosis patients and could be further heightened by
corticotrophin releasing hormone mediated inflammation. Peripheral corticotrophin releasing
hormone increasing with anxiety and emotional stress, might contribute to the peritoneal
inflammation present in endometriosis [28,29].
6. Gastrointestinal symptoms, the menstrual cycle and endometriosis
An increase in the prevalence of gastro-intestimal symptoms are noted around the time of
menses and early menopause [30]. These are periods in the reproductive cycle whereby a
significant decline or low level of ovarian hormones in serum are noted. These observations
suggest that estrogen and progesterone withdrawal may contribute either directly or indirectly
to the occurrence of gastrointestinal symptoms and possibly to pathology [30].
Due to significant overlap between the symptoms of endometriosis and symptoms related to
endometriotic deposits on the gastrointestinal system, endometriosis has been referred to the
great masquerader. Moreover the menstrual cycle may also impact on gastrointestinal
function. As confirmed in the general literature, the presence of frequent menstruation in our
study in patients with endometriosis increased the likelihood of related gastrointestinal
symptoms.
Abdominal symptoms are significantly more pronounced at the beginning of the menstrual
cycle in the follicular phase [14]. Around 30% of otherwise asymptomatic women may
experience gastrointestinal symptoms at the time of menstruation, and almost fifty percent of
women with irritable bowel syndrome complain of a perimenstrual increase in symptoms.
Nausea, epigastric pain, and loose stools diarrhoea are more prevalent at the time of menses
in women complaining of bowel dysfunction. Patients complaining of bowel motility symp‐
toms indicate that stomach pain was higher throughout the menstrual cycle. Patients with
endometriosis complained of cramping pain more commonly in the perimenstrual phase [31].
Intestinal motility disorders may be associated with the genesis of endometriosis and con‐
versely endometriosis may influence intestinal motility. Preclinical studies have shown
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significantly more colonic damage, myeloperoxidase activity, and leucocyte count numbers
than controls did. Increased tension in the longitudinal muscle correlated with leuccytosis and
colonic damage. Mabrouk et al have shown that in deep infiltrating endometriosis, internal
anal sphincter tone was increased in 20 of 25 patients. Responses to a defaecatory function
questionnaire, indicated that incomplete evacuation was the most common symptom [32].
Premenstrual symptoms may be affected by dietary components. Soy products have not been
shown to alter Moos Menstrual Distress scores significantly during premenstrual phase [33].
However the ingestion of total saturated and monounsaturated fats were significantly
correlated with change in Moos Menstrual Distress scores which assesses a number of
premenstrual and menstrual symptomatology and subscale 'pain' in the premenstrual phase
after controlling for the covariates. The consumption of cereals/potatoes/starches was signifi‐
cantly inversely correlated with a change in total Moos Menstrual Distress scores in the
premenstrual phase [33].
Presumably due to hormonal and menstrual differences twice as many women as men seek
health services for irritable bowel syndrome as men. The presence of dyspepsia in women,
was found to be a significant independent risk factor for new-onset irritable bowel syndrome
( [OR] = 2.14; 95% CI, 1.56–2.94). The majority of women with irritable bowel syndrome
requesting medical consultation are of reproductive age experiencing the hormonal fluctua‐
tions of the menstrual cycle. However, after the age of 50 most population surveys have
reported a decline in the prevalence of irritable bowel syndrome[34]. Both oestrogen and
progesterone influence 5-hydroxytryptamine, an amine which is known to effect intestinal
motor-sensory function. During menstruation where oestrogen and progesterone levels reach
their lowest levels in the menstrual cycle, the platelet-depleted plasma concentration of 5-
hydroxytryptamine in irritable bowel syndrome patients with diarrhoea were similar to
healthy controls [35]. Compared to males, females with irritable bowel syndrome more
commonly display non-painful gastrointestinal symptoms, constipation and somatic discom‐
fort. There appear to be different gender-related pathways in sympathetic nervous system
responses to rectosigmoid stimulation. In a study by Chang et al 58 patients with irritable
bowel syndrome underwent barostat-assisted distensions of the rectum and sigmoid colon.
Women with irritable bowel syndrome had significantly lower rectal discomfort thresholds
compared with men with irritable bowel syndrome and healthy women who were the least
sensitive. There were no significant differences in rectal discomfort thresholds between men
with irritable bowel syndrome and healthy men. In both irritable bowel syndrome and control
groups, women demonstrated significantly lower discomfort thresholds after noxious sigmoid
stimulation (P<0.01) compared to men. [36].
Oral contraception results in relatively strict regulation of the menstrual cycle. Moreover the
use of oral contraception is associated with reduced menstrual loss and diminished levels of
dysmenorrhoea. During menstruation, women with irritable bowel syndrome using oral
contraceptives complain of less cognitive, anxiety, and depression symptoms (p < 0.05) but no
differences were seen for most symptoms of irritable bowel syndrome [37]. There may be a
differential effect of oral contraception depending on gastrointestinal symptom pattern.
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The presentation of endometriosis may mimic that of inflammatory bowel disease. Cramping
pain of dysmenorrhea is due to contraction of uterine smooth muscle under the influence of
prostaglandins, released by the endometrium during menstruation. The inflammatory process
in active inflammatory bowel disease is intimately related to prostaglandin levels. Elevated
prostaglandin levels increase contractility of intestinal smooth muscle resulting in diarrhoea
and abdominal pain.
There is critical importance in the clinical distinction between the diagnosis of endometriosis
and inflammatory bowel disease. Nonsteroidal anti-inflammatory drugs are administered to
relieve the symptoms of dysmenorrhoea in the presence and absence of endometriosis.
However Nonsteroidal anti-inflammatory drugs are contraindicated in inflammatory bowel
disease due to the risk of exacerbation of inflammatory bowel disease.
Dietary components in relation to symptomatic Endometriosis and Gastrointestinal symptoms
Psychological stress is also related to injudicious ingestion of dietary components that may
irritate the gastrointestinal tract. Somatization, state and trait anxiety and binge eating are
significant predictors of coexistent gastrointestinal disorders.
Nutrition research suggests that vitamins, minerals, and other dietary components are
important underpinnings of general physical and mental health. Moreover, dietary modifica‐
tion may even be useful in treating mood disorder by providing a more favourable risk-benefit
ratio than contemporary psychotropic agents [38].
The body mass index of women who experience depression is significantly higher than
controls. Meta-analyses confirm a reciprocal link between depressive states and obesity. Self-
confirmed depression, and clinically diagnosed depression are strongly associated with high
body mass index.
6.1. Pharmacological treatment of endometriosis and gastrointestinal symptoms
Anxiety states have been shown to result in excessive ingestion of benzodiazepines, relaxing
lower oesophageal sphincter pressure and subsequently facilitating gastro-oesophageal reflux.
Depression treated with clomipramine was associated with an increased risk of oesophageal
reflux (OR 4.6, 95% CI 2.0-10.6) in a duration- and dose-dependent manner [39].
Moreover, depression and its therapy were found to be predictive of developing obesity. Early
during the first 6 weeks of nortriptyline treatment, weight gain commences, reaching on
average 1.2 kg at 12 weeks with a resultant 0.44% increase in body mass index [40].
Chronic consumption of nonsteroidal anti-inflammatory agents to counter endometriosis-
induced dysmenorrhoea and menorrhagia may lead to ulceration of the gastric mucosa. The
degree of nonsteroidal anti-inflammatory gastropathy may be severe enough to develop
gastric and duodenal ulceration. It appears that there is sufficient evidence to indicate that
administration of nonsteroidal anti-inflammatory drugs could be considerably attenuated and
adverse effects, avoided if medical practitioners were persuaded to change their prescribing
practices [41].




There appears to be co-existence of gastrointestinal symptoms and endometriosis. The linkage
between gastrointestinal symptoms and endometriosis may be due the psychological back‐
ground and neuro-endocrine mediation. Gastrointestinal symptoms have been related to both
dietary indiscretion and psychological stress both of which may, for a variety of reasons, be
commonly encountered in women with endometriosis. Moreover treatment of the symptoms
of endometriosis may aggravate gastrointestinal symptoms.
In suspected endometriosis, meticulous consultation carefully assessing the woman’s symp‐
tomatology is required to avoid delay or possibly misdiagnosis. A delay or misdiagnosis may
further exacerbate the psychological background of anxiety and depression, together with the
incidence of gastrointestinal symptoms. The co-existence of gastrointestinal conditions and
endometriosis may require a multi-disciplinary approach to enact effective treatment.
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